Pfizer Inc.

PFENYSE

$30.28

Last price · USD

Market cap: $172.2B
P/E: 22.3x
EV / EBITDA: 14.2x
P/S: 2.8x
FCF yield: 5.3%
Div. yield: 5.68%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Pfizer Inc. income statement

Annual · USD millions except per-share data · 31 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Revenue & gross profit
Revenue	62,579	63,627	59,553	100,330	81,288	-6.3%
Cost of revenue	18,565	21,781	29,213	38,240	34,413	-14.3%
Gross profit	44,014	41,846	30,340	62,090	46,875	-1.6%
Operating expenses & income
Research & development	11,976	10,738	10,578	11,426	13,828	-3.5%
General & administrative	0	11,430	0	0	0	—
Selling & marketing	0	3,300	0	0	0	—
SG&A (combined)	13,346	14,730	14,470	13,115	12,254	+2.2%
Total operating expenses	28,577	25,363	25,048	24,541	26,082	+2.3%
Cost and expenses	47,142	47,144	54,261	62,781	60,495	-6.0%
Operating income	15,437	16,483	5,292	37,549	20,793	-7.2%
Non-operating & other
Interest income	603	545	1,624	251	36	+102.3%
Interest expense	2,671	3,091	2,209	1,238	1,291	+19.9%
Net interest income	(2,068)	(2,546)	(585)	(987)	(1,255)	—
Non-operating income (excl. interest)	5,246	5,369	2,025	1,582	(4,809)	—
Other expenses	3,255	(105)	0	0	0	—
Other adjustments to net income	0	0	0	0	1	—
Total other income (expenses), net	(7,917)	(8,460)	(4,234)	(2,820)	3,518	—
Profitability
Depreciation & amortization	6,592	7,013	6,290	5,064	5,191	+6.2%
Income before tax	7,520	8,023	1,058	34,729	24,311	-25.4%
Income tax expense	(266)	(28)	(1,114)	3,328	1,852	—
Net income from continuing operations	7,786	8,051	2,172	31,401	22,459	-23.3%
Net income from discontinued operations	25	11	0	(1)	(268)	—
Net income deductions	0	(11)	14	0	1	—
Net income	7,770	8,020	2,133	31,365	22,147	-23.0%
Bottom line net income	7,745	8,031	2,119	31,365	22,146	-23.1%
Additional fields
Ebit	10,191	11,114	3,267	35,967	25,602	-20.6%
Ebitda	16,783	18,127	9,557	41,031	30,793	-14.1%
Eps	$1.36	$1.42	$0.38	$5.59	$3.95	-23.4%
Eps Diluted	$1.36	$1.41	$0.37	$5.47	$3.88	-23.1%
Weighted Average Shs Out	5,683	5,664	5,643	5,608	5,601	+0.4%
Weighted Average Shs Out Dil	5,686	5,700	5,709	5,733	5,708	-0.1%

Pfizer Inc.

PFENYSE

$30.28

Last price · USD

Market cap: $172.2B
P/E: 22.3x
EV / EBITDA: 14.2x
P/S: 2.8x
FCF yield: 5.3%
Div. yield: 5.68%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Pfizer Inc. income statement

Annual · USD millions except per-share data · 31 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Revenue & gross profit
Revenue	62,579	63,627	59,553	100,330	81,288	-6.3%
Cost of revenue	18,565	21,781	29,213	38,240	34,413	-14.3%
Gross profit	44,014	41,846	30,340	62,090	46,875	-1.6%
Operating expenses & income
Research & development	11,976	10,738	10,578	11,426	13,828	-3.5%
General & administrative	0	11,430	0	0	0	—
Selling & marketing	0	3,300	0	0	0	—
SG&A (combined)	13,346	14,730	14,470	13,115	12,254	+2.2%
Total operating expenses	28,577	25,363	25,048	24,541	26,082	+2.3%
Cost and expenses	47,142	47,144	54,261	62,781	60,495	-6.0%
Operating income	15,437	16,483	5,292	37,549	20,793	-7.2%
Non-operating & other
Interest income	603	545	1,624	251	36	+102.3%
Interest expense	2,671	3,091	2,209	1,238	1,291	+19.9%
Net interest income	(2,068)	(2,546)	(585)	(987)	(1,255)	—
Non-operating income (excl. interest)	5,246	5,369	2,025	1,582	(4,809)	—
Other expenses	3,255	(105)	0	0	0	—
Other adjustments to net income	0	0	0	0	1	—
Total other income (expenses), net	(7,917)	(8,460)	(4,234)	(2,820)	3,518	—
Profitability
Depreciation & amortization	6,592	7,013	6,290	5,064	5,191	+6.2%
Income before tax	7,520	8,023	1,058	34,729	24,311	-25.4%
Income tax expense	(266)	(28)	(1,114)	3,328	1,852	—
Net income from continuing operations	7,786	8,051	2,172	31,401	22,459	-23.3%
Net income from discontinued operations	25	11	0	(1)	(268)	—
Net income deductions	0	(11)	14	0	1	—
Net income	7,770	8,020	2,133	31,365	22,147	-23.0%
Bottom line net income	7,745	8,031	2,119	31,365	22,146	-23.1%
Additional fields
Ebit	10,191	11,114	3,267	35,967	25,602	-20.6%
Ebitda	16,783	18,127	9,557	41,031	30,793	-14.1%
Eps	$1.36	$1.42	$0.38	$5.59	$3.95	-23.4%
Eps Diluted	$1.36	$1.41	$0.37	$5.47	$3.88	-23.1%
Weighted Average Shs Out	5,683	5,664	5,643	5,608	5,601	+0.4%
Weighted Average Shs Out Dil	5,686	5,700	5,709	5,733	5,708	-0.1%